Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lobaplatin, 5-FU, and Leucovorin for Recurrent or Metastatic Esophageal Carcinoma
NCT01034683Phase 3Unknown
- Sponsor
- Taian Cancer Hospital
- Start
- Dec 2009
- Primary completion
- Dec 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of lobaplatin in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Taian Cancer Hospital. Status: unknown.
02
Drugs
lobaplatin
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT01034683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01034683.